ArticleFrontiers in immunology2026
Podocyte Vps34 deficiency drives early-onset glomerulopathy and mesangial IgA-dominant immune-complex deposition: a novel mouse model linking vesicular trafficking to glomerular immune dysregulation.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Podocytes are indispensable for maintaining glomerular filtration barrier integrity and immune homeostasis. Although vacuolar protein sorting 34 (Vps34), a class III phosphoinositide 3-kinase, orchestrates intracellular membrane trafficking, its roles in glomerular immune regulation remain incompletely defined. This study identifies a critical link between podocyte-specific Vps34 dysfunction and glomerular immune injury, characterized by pronounced mesangial IgA deposition. Methods: A podocyte-selective Vps34 knockout mouse model was generated. Kidney architecture and function were systematically assessed using histological, immunofluorescent, and ultrastructural analyses. Systemic immunoglobulin concentrations were measured, and bulk renal transcriptomics were conducted to delineate molecular alterations. Results: Selective deletion of Vps34 in podocytes induced rapid-onset proteinuria from three weeks of age, progressive renal failure, and early mortality (median survival nine weeks). These mice exhibited marked mesangial expansion, focal and global glomerulosclerosis, and widespread foot process effacement. Immunofluorescence revealed intense mesangial IgA deposition, accompanied by elevated serum IgA and IgM and reduced IgG levels. Comprehensive transcriptomic profiling revealed progressive immune-related transcriptional changes, highlighting upregulation of antigen presentation, B cell activation, cytokine signaling, and extracellular matrix remodeling. In addition, Vps34 deficiency was associated with increased expression of DAMP-associated and inflammasome-related genes, suggesting engagement of inflammation-related transcriptional programs within the injured kidney. Conclusions: Podocyte-specific Vps34 deficiency leads to progressive podocyte injury accompanied by IgA-dominant immune-complex deposition and immune-related changes in the kidney. These findings reveal an association between podocyte dysfunction and glomerular immune abnormalities and suggest a potential role of vesicular trafficking defects in immune dysregulation during proteinuric kidney disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.